We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Global COVID-19 Antigen Test Market to Continue Being Driven by Evolution of New SARS-CoV-2 Strains

By LabMedica International staff writers
Posted on 22 Sep 2021
The global COVID-19 antigen test market is witnessing increasing demand due to the evolution of new strains of the SARS-CoV-2 virus and increasing spikes in the instances of new COVID-19 infections.

These are the latest findings of Transparency Market Research (Albany, NY, USA), a next-generation market intelligence provider.

Products in the global COVID-19 antigen test market are expected to gain traction owing to their benefits such as shorter test-to-result timeline, as well as their patient-friendly and easy-to-use nature. More...
Furthermore, scalability and timeline challenges regarding PCR testing for the SARS-CoV-2 virus are among the major factors resulting in increased uptake of products in the global COVID-19 antigen test market. Moreover, the emergence of several COVID-19 variants in countries such as Brazil, the UK, and South Africa has intensified the requirement for enhanced and rapid testing products, thus fueling the growth of the global COVID-19 antigen test market. Increasing concerns over the frequency as well as spread of these variants are also anticipated to favor the expansion of the global COVID-19 antigen test market. Furthermore, increased demand for low cost rapid test kits for conducting large scale testing in order to control the spike in COVID-19 cases in various underdeveloped economies is also expected to favor the expansion of the global COVID-19 antigen test market over the coming years.

Additionally, the rising number of product approvals as well as emergency use authorizations by regulatory bodies, coupled with various technological collaborations between several operating entities, is expected to intensify the competitive landscape of the global COVID-19 antigen test market, going forward. Geographically, Asia Pacific is anticipated to account for the largest share of the global COVID-19 antigen test market in terms of revenue, mainly due to the strong presence of various regional and local players who are actively innovating newer antigen tests, as well as the introduction of various new products by several up and coming start-ups in the region.

Related Links:

Transparency Market Research


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.